ArticleHepatology international2023

Comparative efficacy of PD-1 inhibitors plus lenvatinib and regorafenib after lenvatinib failure for advanced hepatocellular carcinoma: a real-world study.

Renguo Guan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.